Clinical Trials Browser

INDUSTRY × ibrutinib × Tumor-Agnostic × Clear all

NCT01704963 2018-02-05

A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms

Phase 1 Completed

Neoplasms